Breast cancer cells can directly stimulate osteoclastogenesis by secreting factors such as receptor activator of nuclear factor kappa-Β ligand (RANKL), IL-1, IL-6, and tumor necrosis factor-alpha (TNF-α) (Le Pape et al., 2016). The gene discussed is IL1B; the disease is breast carcinoma.